Monogram Orthopaedics (NASDAQ:MGRM) Issues Earnings Results

Monogram Orthopaedics (NASDAQ:MGRM) announced its earnings results on Thursday. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.09) by ($0.02), Zacks reports. During the same quarter in the prior year, the business posted ($0.27) earnings per share.

Monogram Orthopaedics Price Performance

Shares of NASDAQ:MGRM traded up $0.03 during midday trading on Friday, reaching $2.82. The company had a trading volume of 62,426 shares, compared to its average volume of 122,295. The stock has a market capitalization of $89.31 million, a P/E ratio of -5.64 and a beta of 2.21. Monogram Orthopaedics has a one year low of $1.53 and a one year high of $5.15. The stock’s fifty day moving average price is $2.27 and its 200-day moving average price is $2.38.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.